T 0203/23 (Controlled release levodopa/IMPAX) of 28.11.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T020323.20241128
- Date of decision
- 28 November 2024
- Case number
- T 0203/23
- Petition for review of
- -
- Application number
- 08866933.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
- Applicant name
- Impax Laboratories, LLC
- Opponent name
- Luigi, Rumi
Teva Pharmaceutical Industries Ltd - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention R 103(1)(a)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Right to be heard - substantial procedural violation (no)
Amendments - added subject-matter (yes)
Auxiliary request filed at the oral proceedings - cogent reasons (no) - Catchword
- -
- Cited cases
- G 0001/16
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appeal is dismissed.
2. The appellant's request for reimbursement of the appeal fee is rejected.